Logo image
Stereotactic Body Radiation Therapy in the Management of Recurrent Unresectable Retroperitoneal Ganglioneuroma
Journal article   Open access   Peer reviewed

Stereotactic Body Radiation Therapy in the Management of Recurrent Unresectable Retroperitoneal Ganglioneuroma

Bradley Callas, Shyam Jani, Isheeta S Govardhan, Nitika Thawani and Shyamal Patel
Curēus (Palo Alto, CA), Vol.18(1), p.e102628
01/30/2026
PMID: 41773119

Abstract

Oncology Radiation Oncology
Ganglioneuromas are rare, benign tumors arising from neural crest cells, typically managed with surgical resection. We present a unique case of a 35-year-old man with a history of ganglioneuroma resected in early childhood, who developed a recurrent retroperitoneal mass more than 30 years later. Imaging revealed a 12 cm lesion encasing critical structures, rendering it surgically unresectable. The patient underwent stereotactic body radiotherapy (SBRT), receiving 40 Gy in five fractions using volumetric modulated arc therapy (VMAT). Treatment was well-tolerated with no significant toxicity. Follow-up imaging over two years demonstrated stable disease without progression or symptom recurrence. To our knowledge, this is the first reported case of SBRT utilized for a retroperitoneal ganglioneuroma, highlighting its potential as a noninvasive alternative in cases where surgery is contraindicated. This case underscores the importance of long-term surveillance in patients with previously resected ganglioneuromas and suggests that SBRT may be a viable treatment option when surgical intervention poses significant risks.
url
https://doi.org/10.7759/cureus.102628View
Published (Version of record) Open

Metrics

1 Record Views

Details

Logo image